Home Page
08:52:06 EST Wed 26 Nov 2014
Enter Symbol
or Name
USA
CA



Z:SNY - SANOFI - http://www.sanofi-aventis.com08:52:06 EST
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
SNY - Z2.047.68 · 47.725.047.651157.42  44.5007:08:13Nov 2115 min RT 2¢

Recent Bulletins
Date ETSymbolTypeHeadline
2014-11-21 07:15SNYNews ReleaseEuropean CHMP Adopts Positive Opinion for Genzyme’s Cerdelga® (eliglustat) Capsules
2014-11-20 01:30SNYNews ReleaseRegeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis
2014-11-19 08:15SNYNews ReleaseSanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol
2014-11-19 08:15SNYNews ReleaseRegeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol
2014-11-18 15:45SNYNews ReleaseGenzyme and Isis Present KYNAMRO® Clinical Data at the American Heart Association
2014-11-18 11:22SNYNews ReleaseSanofi Names Chief Scientific Officer Gary Nabel as Sanofi Ebola Response Coordinator
2014-11-14 21:00SNYNews ReleaseGenzyme’s Lemtrada Approved by the FDA
2014-11-11 01:00SNYNews ReleaseRegeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma
2014-11-04 06:00SNYNews ReleaseGenzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis
2014-11-03 08:30SNYNews ReleaseSanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older
2014-10-30 09:00SNYNews ReleaseSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sanofi

Recent Trades - All 1 today
Time ETExPriceChangeVolume
07:08:13Z47.720.0721